The Latest Breaking News from FDA

In the past, US consumers have resisted their favorite foods changing to natural dyes. Attitudes might shift if Maha converts the entire industry

The word “natural” on a product label can be powerfully persuasive, making consumers feel like they are choosing a healthier, safer, and more wholesome option. However, the Food and Drug Administration (FDA) has no formal, regulated definition for the term “natural.” This allows manufacturers to use it as a marketing…

Moderna Inc.’s (NASDAQ:MRNA) stock has surged approximately 37% in the last month but has dipped around 15% year to date.

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ingredients from China, Reuters reported recently.

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are dangerous.

Dozens of tuna salad products have been recalled from stores in seven US states due to possible listeria contamination, a bacteria that can lead to deadly infections like listeriosis.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced the collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening System, strengthening its FDA 510(k) submission.

Abivax SA (NASDAQ:ABVX) stock is skyrocketing on Wednesday after the clinical-stage biotechnology company announced overwhelmingly positive topline results from its Phase 3 ABTECT-1 (Study 105) and ABTECT-2 (Study 106) 8-week induction trials for oral obefazimod (ABX464) in adult patients with moderately to severely active ulcerative colitis.

OFA Group (NASDAQ:OFAL) experienced an increase in its stock value after hours on Tuesday. The company’s stock value surged by 69.94% to $2.94.